Abstract The source of precursor lesions of squamous cell carcinoma (SCC) of the oral cavity and pharynx, their classification, and grading are controversial. In contrast, vulvar and penile cancer precursor lesions are known to be related to human papillomavirus or chronic inflammation and can be described using the vulvar intraepithelial neoplasia (VIN) classification system (VIN 1-3) or as differentiated vulvar intraepithelial neoplasia (dVIN), respectively. Oral and pharyngeal SCC precursor lesions are more etiologically diverse, and the spectrum of lesions may thus be wider. No international consensus exists regarding the histological types of precursor lesions or the significance of individual types. We therefore reviewed resection specimens and preceding biopsies of 155 patients with SCC of the oral cavity and pharynx (excluding tonsils) and identified five basic patterns of SCC-associated or precursor lesions: (1) pleomorphic (22/155), (2) basaloid (5/155), (3) differentiated (63/155), (4) mixed (42/155), and (5) verrucous (12/155). Keratinization was a common but variable feature in differentiated, mixed, and verrucous dysplasia. In 11/155 patients, no precursor lesion could be identified. Progression of isolated differentiated dysplasia (ranging from months to years) was documented in 13/155 (8 %) of patients. Our data suggest that full-thickness epithelial dysplasia of pleomorphic or basaloid type is present in <20 % of oral and pharyngeal SCC, and differentiated dysplasia is a frequent precursor or associated in situ lesion. Failure to recognize differentiated dysplasia results in the underdiagnosis of many patients at risk for invasive carcinoma. These results indicate a need to refine criteria to distinguish differentiated dysplasia from morphologically related lichenoid lesions.
Introduction
The grading of invasive squamous cell carcinoma (SCC) can be traced back to Broders [1] , and the grading of SCC precursor lesions, to Papanicolaou [2] . Subsequently, the progression from mild to moderate to severe dysplasia in the squamocolumnar epithelial junction of the uterine cervix has been considered paradigmatic. This paradigm still influences concepts of cancer precursor lesions in various epithelia [3] [4] [5] .
Historically, cervical cancer precursor lesions were graded according to the cervical intraepithelial neoplasia (CIN) system (CIN 1-3), where dysplastic changes are confined to the lower third of the epithelium in CIN 1, found in the lower two thirds of the epithelium in CIN 2, and involve the full thickness of the epithelium in CIN 3. Although later challenged by patient follow-up studies, epidemiological data were interpreted as evidence that progression from CIN 1 to invasive SCC was a stepwise process with single-step intervals of approximately 7 years. Eventually, it was recognized that this concept does not reflect biology [6] . The different grades of dysplasia are due to low-and high-risk human papillomavirus (HPV) types, which are responsible for more than 99 % of cervical dysplasia. Low-risk HPV types cause low-grade squamous intraepithelial lesions and can give rise to condylomata, whereas high-risk HPV types cause high-grade squamous intraepithelial lesions. Viral proteins E6 and E7 of the high-risk HPV types form complexes with cellular p53, resulting in p53 inactivation and the accumulation of mutations, leading to invasive SCC. The concept of stepwise progression from CIN 1 to 3 appears to represent an exception to the rule, typically reflecting an infection with both high-and low-risk HPVs [7] . Therefore, the traditional idea of morphological progression is, at least in the uterine cervix, a reflection of independent etiologies rather than a true biological progression [8] [9] [10] [11] [12] .
In vulvar cancer, different etiologies are associated with distinct morphological features. HPV-associated carcinogenesis can be classified by using the traditional vulvar intraepithelial neoplasia (VIN) grading system (VIN 1-3), which is gradually being replaced by the low/high-grade squamous intraepithelial lesion system. Chronic inflammationassociated carcinogenesis (e.g., lichen planus or lichen sclerosus) is classified using the simplex or differentiated VIN system. In vulvar carcinogenesis, conventional highgrade dysplasia associated with high-risk HPV has been linked to higher-grade invasive SCC (G2/3), whereas inflammation-associated differentiated dysplasia most often gives rise to lower grades of invasive SCC (G1/2) [6, [13] [14] [15] [16] [17] [18] . Analogous findings have been reported for penile SCC and its precursor lesions [19] [20] [21] [22] [23] [24] .
The recognition and grading of SCC precursor lesions of the upper aerodigestive tract is controversial [3] [4] [5] 25] . Many facets appear heavily influenced by the traditional cervical cancer precursor lesion progression paradigm, and innovation, as reflected by internationally accepted classification schemes, appears limited [26] .
The field is complicated by a wider spectrum of etiological agents, namely, HPV, inflammation (e.g., oral lichen planus), smoking, alcohol consumption, and substance chewing (e.g., areca nut and betel quid) [27] . Accordingly, a wider spectrum of histological precursor lesions could be expected that do not well fit into the onedimensional cervical cancer precursor lesion progression paradigm. Additionally, a wide spectrum of clinical lesions has been recognized, including leukoplakia, erythroplakia, lichenoid lesions, and proliferative verrucous leukoplakia, which do not correlate well with histological precursor lesions and cancer risk [28, 29] .
The current grading system considers full-or near-fullthickness dysplasia with significant nuclear atypia as high grade and high risk for invasive SCC development, and nonfull-thickness dysplasia with milder nuclear atypia as low risk. Non-full-thickness dysplasia can be categorized as high grade/high risk if basal/suprabasal atypia is significant [3] . Other lesions are predominantly defined by clinical features, such as proliferative verrucous leukoplakia [30] and lichenoid dysplasia [31, 32] . These defy classification within a conventional grading system and carry an ill-defined but often high risk of progression to invasive SCC.
We carried out this retrospective study of 155 patients with oral and pharyngeal SCC to obtain an unbiased overview of precursor lesions adjacent to invasive or preceding SCC. We addressed the following questions: (1) What are the relative frequencies of conventional full-thickness dysplasia versus non-full-thickness dysplasia adjacent to invasive SCC? (2) Are full-thickness dysplasia and non-fullthickness dysplasia associated with distinct carcinoma types? (3) What is the role of full-thickness dysplasia in the progression of precursor lesions to invasive SCC?
Patients, materials, and methods
Patient selection
We searched the database of the Institute of Pathology of the Cantonal Hospital Aarau for patients with SCC of the oral cavity and pharynx (excluding tonsils). The search covered the period from 1990 to 2009. We retrieved all excision specimens and preceding biopsies on file. Mean patient age was 59.6 years (median 59 years), and the male/female ratio was 2:1 ( Table 1) . We did not have anamnestic data regarding carcinogen exposure or HPV status.
Histological review
We evaluated the excision specimens of invasive cancer for cancer grade and adjacent cancer precursor lesions. The preceding biopsies without invasive carcinoma were evaluated for carcinoma precursor lesions. We classified the carcinoma-associated or preceding lesions as full-versus non-full-thickness dysplasia. The series was reviewed three times by two independent pathologists. Invasive SCC was graded according to Anneroth's multifactorial grading system [43] .
Dysplasia categories
Dysplasia was divided into five categories (Table 2, Figs. 1 and 2). Full-thickness dysplasia was divided into basaloid and pleomorphic types, both of which are considered severe dysplasia by conventional grading. Non-full-thickness dysplasia was divided into differentiated, verrucous, and a mixed form of non-full-thickness dysplasia with either isolated basal and suprabasal dysplasia with regular superficial maturation or additional superficial features of differentiated or verrucous dysplasia. Differentiated dysplasia has previously been referred to as lichenoid or simplex dysplasia, and verrucous dysplasia shares features with proliferative verrucous leukoplakia. Cases of mixed dysplasia included cases of moderate dysplasia according to the World Health Organization grading system and cases of keratinizing dysplasia.
Time course in patients with sequential biopsies Special attention was paid to patients who did not show invasive SCC on the initial biopsy. Review of clinical information ascertained that the specimen showing invasive carcinoma originated from the same anatomical location as the earlier biopsy.
Results
In our retrospective series of 155 patients, we determined the number and relative frequency of each SCC precursor lesion type adjacent to or preceding invasive SCC of the oral cavity and pharynx (Table 3) . Full-thickness forms of SCC precursor lesions were observed in only 17 % of cases with detectable dysplasia. Even when adding mixed dysplasia to basaloid and pleomorphic dysplasia to represent conventional forms of dysplasia, they comprised less than half of our cases (44 %). Non-full-thickness forms of dysplasia (i.e., mixed, differentiated, and verrucous) represented more than 80 % of all dysplasia. Differentiated forms of dysplasia were identified as the sole associated cancer precursor lesion in nearly half of the cases with identifiable dysplasia. This suggests that development of invasive SCC of the oral cavity and pharynx via conventional full-thickness dysplasia represents the exception, whereas development via non-fullthickness dysplasia represents the rule. Table 4 shows precursor lesions according to grade of invasive SCC. Full-thickness forms of dysplasia were exclusively associated with higher grades of invasive SCC, with basaloid dysplasia associated mainly with poorly differentiated (G3) SCC, and pleomorphic dysplasia associated with both G2 and G3 SCCs.
Non-full-thickness forms of dysplasia (i.e., mixed, differentiated, and verrucous) showed a heterogeneous pattern. Mixed dysplasia was associated primarily with G2 SCC, whereas differentiated and verrucous dysplasia were associated primarily with G1 and G2 SCC. This suggests that fullthickness dysplasia leads to higher-grade SCC, whereas non-full-thickness dysplasia, specifically differentiated and verrucous dysplasia, leads to lower-grade SCC.
We next evaluated the progression from dysplasia to invasive SCC in 24 patients. Most patients had invasive SCC on the initial biopsy. Figure 3 shows only those patients who did not show invasive SCC on their initial biopsy. Of these 24 patients, four had clinically obvious malignant lesions and underwent a second biopsy within weeks. Twenty patients had initial diagnoses including hyperplasia, inflammation, and mild/moderate dysplasia and underwent additional biopsies at variable intervals. The initial biopsy was used to categorize precursor lesions. In accordance with the study design, all patients eventually developed invasive SCC within the time range shown in Fig. 3 .
In all but five cases, the category of dysplasia adjacent to the invasive carcinoma was identical to the dysplasia category on the first biopsy specimen. In one case of mixed dysplasia on initial biopsy, the next excision specimen with invasive SCC showed adjacent pleomorphic dysplasia. In another case of mixed dysplasia, the excision specimen 2 years later showed both mixed and verrucous dysplasia. In two cases of differentiated dysplasia, the excision specimen obtained years later showed both differentiated and verrucous dysplasia. In one case of differentiated dysplasia, the precursor lesion shifted or progressed to mixed dysplasia. This suggests that dysplasia tends to remain in the same category over time rather than progress from one category to another. Specifically, there is no evidence for progression from non-full-to full-thickness dysplasia in the development of invasive SCC. Table 4 shows that verrucous and differentiated dysplasia tended to develop into lower-grade (G1 and G2) invasive SCC, mixed dysplasia into G2 SCC, and pleomorphic and basaloid dysplasia into both G2 and G3 SCCs, even if detection or development of invasive SCC was delayed after the initial biopsy.
Discussion
We analyzed a series of 155 patients with invasive SCC of the oral cavity and pharynx to evaluate associated adjacent or preceding cancer precursor lesions. We categorized precursor lesions into five different groups rather than grades of dysplasia. Grading can be applied within individual categories, each category with its own cytological and architectural grading criteria. A precedent for this can be found in data on the oral cavity and squamous epithelia of the penile and vulvar mucosa [19, 21, 23, 24] , encompassing the conventional VIN/penile intraepithelial neoplasia (PeIN) and differentiated VIN/differentiated PeIN paradigms, and in colorectal cancer, in which sessile serrated adenomas have recently been separated from the traditional adenomatous pathway [33] . In both organ systems, grading criteria are specific to the individual morphological pathways. The Japanese Society of Oral Pathology (JSOP) advocates a system with three categories (i.e., basaloid, differentiated, and mixed), which is similar to our system [26, 29] . In contrast to the JSOP system, we divided full-thickness dysplasia into basaloid and pleomorphic types, which we hypothesize to have distinct etiologies and molecular carcinogenic pathways [34] . In a recent study, the spectrum of mixed and differentiated dysplasia was addressed by Kobayashi et al. [35] and referred to as orthokeratotic dysplasia. We chose to separate differentiated dysplasia from verrucous dysplasia, which is known as proliferative verrucous leukoplakia [30, 36, 37] but has also been referred to as verrucous hyperplasia [38] [39] [40] . Within penile and vulvar squamous epithelia, the separation of differentiated dysplasia (including warty or verrucous forms) from basaloid or pleomorphic dysplasia is well established.
In contrast to Chaux et al. [24] , we categorized cases with striking basal and/or suprabasal atypia apparent at low magnification as mixed dysplasia, reserving the categories of differentiated and warty/verrucous dysplasia to cases with more subtle and/or suprabasal atypia, most of which are easily detected at higher magnification. van de Nieuwenhof [15] recognized differentiated dysplasia in vulvar squamous epithelium by the presence of elongated rete ridges with anastomosis, a disorderly basal cell layer with dyskeratosis, parakeratosis, prominent nucleoli, and atypical mitoses. We recognized a disordered basal cell layer or basal layer atypia in the presence of distinct clustering of three to five often small basal cells with small nuclei, either hyperchromatic or with open chromatin and small but distinct nucleoli. Unlike van de Nieuwenhof, we required distinct changes in the suprabasal cell layer, with large cells containing abundant eosinophilic cytoplasm, distinct desmosomes, large nuclei with open chromatin and large prominent nucleoli, nuclear atypia with variable binucleation, and variation in nuclear shape, membrane thickness, chromatin structure, nucleolar size, shape, distribution, and number. Atypical mitosis and dyskeratosis were sometimes observed but not required for diagnosis.
The criteria for the differentiated dysplasia referred to by Kobayashi et al. [35] as orthokeratotic dysplasia included "disturbed basal cell alignment, conspicuous pleomorphic, or atypical cellular features," and "atypical cells with bizarre nuclei were occasionally scattered in the lower prickle cell layer." We extended these criteria to include the distinct clustering of (often small) basal cells.
Our data show that conventional full-thickness dysplasia represents the exception in oral and pharyngeal SCC development, and non-full-thickness dysplasia (including mixed, differentiated, and verrucous forms) represent the rule. This is consistent with penile and vulvar carcinogenesis, in which differentiated dysplasia represent approximately half of cancer precursor lesions [19, 41] . Similarly, the JSOP reported that most premalignant lesions of the oral mucosa show superficial maturation and differentiation [26] , and Kobayashi et al. [35] reported orthokeratotic dysplasia (i.e., mixed and differentiated dysplasia) in approximately one third of the oral leukoplakia-type SCC cases assessed. In our study, basaloid dysplasia was uncommon. We attribute this result to our exclusion of tonsils, where basaloid carcinomas predominate.
In our series, conventional full-thickness dysplasia is associated with higher-grade SCC, whereas non-full-thickness dysplasia is associated with lower-grade SCC. This is similar to penile and vulvar carcinogenesis, in which differentiated dysplasia are typically associated with well-differentiated carcinomas [6, [13] [14] [15] [16] [17] [18] . Similarly, in penile and vulvar carcinogenesis, conventional high-grade dysplasia has no role in well-differentiated invasive SCC [19] [20] [21] [22] 24] . We acknowledge that the categories used in this study and those described by others [19] were defined within a morphological continuum. However, we hypothesize that different categories may be associated with distinct etiologies and molecular pathways [19, 21, 22, 24, 42] , and it is likely that carcinogenesis is caused by more than one carcinogen and involves more than one pathway. Our results indicate that regardless of the carcinogen and molecular pathway involved, the associated morphological changes and dysplasia category tend to remain stable over time. When sequential biopsies were available over longer periods of time, the initial biopsies showed precursor categories that were almost always identical to the precursor lesion found adjacent to the invasive carcinoma. This supports the concept that morphological findings in dysplasia primarily relate to dysplasia categories, rather than dysplasia grades.
We recruited our patients by searching the pathology database for invasive SCC. Therefore, patients with dysplasia on biopsy and subsequent complete excision were not included in this study because they would not have developed invasive SCC. For this reason, our study cannot estimate the relative proportion of each dysplasia category in all patients but focuses on dysplasia categories in cases that progressed to invasive SCC. Our findings are consistent with a previous report [26] .
Likewise, our study does not provide definitive data on the dynamics (likelihood and time course) of progression of non-full-thickness dysplasia, specifically differentiated dysplasia, to invasive carcinoma. The JSOP [26, 29] suggests that differentiated dysplasia progress to invasive carcinoma within 5 years, whereas conventional dysplasia progress within 6 months. This is in line with our data showing that isolated pleomorphic and basaloid dysplasia typically progressed to invasive carcinoma within 6 months, whereas mixed and differentiated categories progressed to invasive carcinoma over longer intervals (≥8 years), with most progressing within 3 years. The more rapid progression of verrucous precursor lesions supports their relationship to proliferative verrucous leukoplakia.
We did not address the morphological criteria used to distinguish differentiated forms of dysplasia from changes Fig. 3 Time line for the progression of the distinct forms of dysplasia to invasive squamous cell carcinoma in the subset of 24 of our 155 patients, not showing invasive squamous cell carcinoma on the first biopsy specimen (basaloid, n=1; pleomorphic, n=3; mixed, n=5; differentiated, n=13; verrucous; n=2). Each case of later invasive squamous cell carcinoma is identified in the figure by its grade (G1, G2, or G3). Cases are placed on the time line corresponding to the relevant dysplasia category to show the time interval in months between the first biopsy and eventual tissue diagnosis of invasive squamous cell carcinoma on repeat biopsy or excision. In most cases, the category of dysplasia adjacent to the invasive carcinoma was identical to the category observed in the first biopsy specimen. In cases, where the category of dysplasia adjacent to the invasive carcinoma differed from the category retained on the first biopsy specimen, this latter category of dysplasia is indicated by a foot note observed in reactive lesions, such as lichen planus and regenerative squamous epithelium. Instead, we applied criteria used in our daily practice and influenced by the literature on penile and vulvar neoplasia [6, 8, 11, 13, 14, [17] [18] [19] [20] . However, under study conditions, these morphological changes may also represent a continuum, as both lichen planus and chronic regeneration can eventually lead to dysplasia and invasive carcinoma. Until further study, it may be better to limit definitive diagnoses of differentiated forms of dysplasia to cases that do not show significant interface inflammation or causes of regenerative response such as ulceration, chronic trauma, or fungal infection. Alternatively, the criteria for diagnosing differentiated forms of dysplasia may need to be applied stringently.
Nevertheless, we feel confident that the criteria of significant basal cell atypia for mixed dysplasia, basal cell clustering and suprabasal atypia in differentiated dysplasia, and shriveled nuclei in a hyperplastic superficial layer for verrucous dysplasia can provide relevant clinical information. Clinically suspicious lesions that later progress to invasive carcinoma typically show changes that we and others [15, 22] have variably referred to as differentiated forms of dysplasia, simplex dysplasia, or lichenoid dysplasia. The data should thus sensitize both clinicians and pathologists to the relevance of differentiated forms of dysplasia in general and to subtler forms detectable only at high magnification using cytological criteria.
Finally, our data support a conceptual shift, previously suggested by others [14, 26, 42] , away from primary dysplasia grades to SCC precursor categories that may be associated with specific but overlapping carcinogenic and molecular pathways. We hope that this shift will help to overcome the dissatisfaction [3, 4] with the current classification systems of SCC precursor lesions of the oral cavity and pharynx.
